MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$9,336,522
Free Cash flow
-$6,993,472
Unit: Dollar
Positive Cash Flow Breakdown
    • Repayment of debt instruments
    • Accrued expenses
    • Amortization of capitalized soft...
    • Others
Negative Cash Flow Breakdown
    • Net loss from continuing operati...
    • Accounts payable
    • Cash paid for capitalized softwa...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-09-30
Net cash provided by operating activities of discontinued operations
0
-
-
Net loss from continuing operations
7,083,941
-
-
Amortization of capitalized software
1,713,680
-
-
Depreciation
292,787
-
-
Noncash operating lease expense
215,132
-
-
Stock compensation expense
790,112
-
-
Accounts receivable
1,401,041
-
-
Product deposit
-87,766
-
-
Inventory
-220,992
-
-
Other current assets
-1,368,328
-
-
Operating lease liabilities
-155,773
-
-
Deferred revenue
-1,225,619
-
-
Accounts payable
-3,496,210
-
-
Accrued expenses
1,716,223
-
-
Amortization Of Intangible Assets
32,083
-
-
Net cash (used in) provided by operating activities of continuing operations
-6,925,647
-
-
Net cash (used in) provided by operating activities
-6,925,647
-
-
Net cash used in investing activities of discontinued operations
0
-
-
Cash paid for capitalized software costs
1,566,488
-
-
Purchase of equipment
67,825
-
-
Net cash used in investing activities of continuing operations
-1,634,313
-
-
Net cash used in investing activities
-1,634,313
-
-
Net cash used in financing activities of discontinued operations
0
-
-
Repayment of debt instruments
-18,719,721
-
18,719,721
Preferred stock dividends
776,562
-
-
Cash proceeds from exercise of options
0
-
-
Net cash used in financing activities of continuing operations
-776,562
-696,043
-
Net cash used in financing activities
-776,562
-
-
Net (decrease) increase in cash
-9,336,522
-
-
Less net income from discontinued operations
0
-
-
Amortization of debt discount
-234,369
-
234,369
Net cash used in investing activities of discontinued operations
0
-
-
Less cash of discontinued operations at end of period
0
-
-
Cashless exercise of options
0
-
-
Stock issued for debt conversion
0
-
-
Net loss
-11,633,360
-
-4,323,177
Net loss from continuing operations
7,083,941
8,872,596
-
Amortization of capitalized software
1,713,680
-5,412,202
7,087,054
Amortization of intangibles
31,917
-743,421
775,338
Loss on debt extinguishment
-
-
-1,155,851
Depreciation of fixed assets
292,787
-320,111
609,569
Noncash operating lease expense
215,132
-608,837
821,604
Stock compensation expense
790,112
-6,392,273
7,841,178
Accounts receivable
1,401,041
2,159,603
-1,609,763
Product deposit
-87,766
-318,447
329,755
Inventory
-220,992
-231,464
635,024
Other current assets
-1,368,328
628,672
580,382
Operating lease liabilities
-155,773
97,675
-248,574
Deferred revenue
-1,225,619
6,479,475
-5,270,408
Accounts payable
-3,496,210
3,958,717
3,545,251
Accrued expenses
1,716,223
2,906
-731,959
Net cash (used in) provided by operating activities of continuing operations
-6,925,647
444,624
-
Net cash (used in) provided by operating activities
-6,925,647
-11,116,074
11,560,698
Cash paid for capitalized software costs
1,566,488
-6,494,603
8,446,187
Purchase of equipment
67,825
-1,610,036
1,715,214
Net cash used in investing activities of continuing operations
-1,634,313
-2,056,762
-
Sale of common stock under atm, net
-
-
8,721,717
Net cash used in investing activities
-1,634,313
8,104,639
-10,161,401
Preferred stock dividends
776,562
-1,553,125
2,329,688
Cash proceeds from exercise of warrants
-
-
464,950
Cash proceeds from exercise of options
0
74,570
5,950
Distributions to non-controlling interest
-
-
761,658
Net cash used in financing activities
-776,562
11,922,407
-12,618,450
Net (decrease) increase in cash
-9,336,522
8,910,972
-11,219,153
Cash at beginning of period
23,785,771
23,785,771
35,004,924
Cash at end of period
25,141,615
34,478,137
23,785,771
Cash of continuing operations at end of period
25,141,615
34,478,137
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net (decrease)increase in cash-$9,336,522 Net cash (used in)provided by operating...-$6,925,647 Net cash used ininvesting activities-$1,634,313 Net cash used infinancing activities-$776,562 Accrued expenses$1,716,223 Amortization of capitalizedsoftware$1,713,680 Other current assets-$1,368,328 Stock compensationexpense$790,112 Depreciation$292,787 Inventory-$220,992 Noncash operating leaseexpense$215,132 Product deposit-$87,766 Amortization Of IntangibleAssets$32,083 Repayment of debtinstruments-$18,719,721 Net cash (used in)provided by operating...-$6,925,647 Net cash used ininvesting activities of...-$1,634,313 Net cash used infinancing activities of...-$776,562 Canceled cashflow$6,437,103 Canceled cashflow$18,719,721 Net loss fromcontinuing operations$7,083,941 Cash paid forcapitalized software costs$1,566,488 Purchase of equipment$67,825 something is missing-$18,719,721 Accounts payable-$3,496,210 Accounts receivable$1,401,041 Deferred revenue-$1,225,619 Operating leaseliabilities-$155,773 Preferred stock dividends$776,562

LifeMD, Inc. (LFMDP)

LifeMD, Inc. (LFMDP)